Academically Reviewed TrialNHS Shropshire · University of Copenhagen

The Clinical Evidence.
Irrefutable.

An independent academically reviewed trial — conducted through NHS Shropshire and analysed at the University of Copenhagen — confirms that The Linden Method produces a highly statistically significant reduction in anxiety condition symptoms across all major diagnostic categories.

View Trial Results About TRT

84.5%Reduction in Anxiety Score

18.28 → 2.84GAD-7 Score Pre & Post

p < .001Statistical Significance

61Trial Participants

The Study

The Efficacy of The Linden Method in Eliminating Anxiety Symptoms

Martin Jensen — Kingston University / University of Copenhagen · Commissioned through NHS Shropshire

The Linden Method is a structured programme for the treatment of anxiety conditions including GAD, Panic Disorder, Agoraphobia, OCD, PTSD, and anxiety-related low mood. The present study investigated its efficacy in a cohort of clients who had followed the programme as directed, using the internationally validated GAD-7 scale.

Methodology

Study Design & Participant Selection

Participants were selected on the basis that they had complied with the programme as directed — mirroring the methodology applied in pharmaceutical drug trials. Of 100 invitations, 61 agreed to take part.

MeasureGAD-7

Internationally validated anxiety scale (Spitzer et al., 2006)

AnalysisIBM SPSS

Wilcoxon signed-rank test for non-parametric ordinal data

AssessmentPre & Post

Retrospective self-report at both pre- and post-treatment stages

Results

Highly Significant Reduction in Anxiety Severity

The mean pre- and post-treatment GAD-7 scores for participants were 18.28 and 2.84 respectively. This indicates that a large proportion of participants entered the programme with severe anxiety — the highest category on the GAD-7 scale. Post-treatment results demonstrate that, for the overwhelming majority of participants, anxiety no longer presented as a significant issue in day-to-day life.

A Wilcoxon signed-rank test confirmed that adhering to The Linden Method programme resulted in a highly statistically significant change in self-reported anxiety distress when pre- and post-treatment levels were compared, with the post-treatment group reporting substantially fewer anxiety symptoms (Z = −6.802, p < .001).

Pre-Treatment Distribution

Mean: 18.28

GAD-7 score category at programme entry (n = 61)

Minimal (0–4)

Mild (5–9)

11%

Moderate (10–14)

20%

Mod. Severe (15–18)

59%

Severe (>18)

Post-Treatment Distribution

Mean: 2.84

GAD-7 score category after completing the programme (n = 61)

80%

Minimal (0–4)

13%

Mild (5–9)

Moderate (10–14)

Mod. Severe (15–18)

Severe (>18)

* GAD-7 categories: 0–4 Minimal · 5–9 Mild · 10–14 Moderate · 15–18 Moderately Severe · >18 Severe. Score <5 considered within normal range.

"Participants, many of whom reported severe anxiety symptoms pre-treatment, improved significantly using The Linden Method programme for anxiety elimination."

— Martin Jensen, Kingston University / University of Copenhagen

Discussion

What the Evidence Means

The results indicate a fundamental shift in anxiety baseline — not suppression or management. A post-treatment mean of 2.84 places the average participant well within "minimal anxiety," below the clinical threshold of 5. Data were collected retrospectively using programme-compliant participants — standard methodology, directly comparable to pharmaceutical efficacy trials.

Study Reference

Jensen, M. The efficacy of The Linden Method in eliminating anxiety symptoms in a cohort of anxiety sufferers. Kingston University / University of Copenhagen. Commissioned through NHS Shropshire. GAD-7 assessment instrument: Spitzer, R.L., Kroenke, K., Williams, J.B. & Löwe, B. (2006). A brief measure for assessing generalised anxiety disorder: the GAD-7. Archives of Internal Medicine, 22(10), pp. 1092–1097.

View all research publications

You've seen the proof — now take the first step

GAD-7 18.28 → 2.84.
What would that change look like in your life?

The trial participants were exactly where you are now. They followed the same programme available today. No prescription. No waiting list. No ongoing management.

Start Your Recovery Today →Speak to the Institute

At a Glance

18.28
Mean pre-treatment GAD-7 score (severe anxiety category)
2.84
Mean post-treatment GAD-7 score (minimal anxiety — below clinical threshold)
−6.802
Wilcoxon Z-statistic — indicating an extremely large treatment effect
p < .001
Statistical significance — the result would occur by chance less than once in 1,000 trials
61
Participants who completed the programme and took part in the study